Summary
Biotechnology in China industry profile provides top-line qualitative and quantitative summary information including: market size (value 2012-16, and forecast to 2021). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.
Synopsis
- Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the biotechnology market in China
- Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the biotechnology market in China
- Leading company profiles reveal details of key biotechnology market players' global operations and financial performance
- Add weight to presentations and pitches by understanding the future growth prospects of the China biotechnology market with five year forecasts
Reasons To Buy
- What was the size of the China biotechnology market by value in 2016?
- What will be the size of the China biotechnology market in 2021?
- What factors are affecting the strength of competition in the China biotechnology market?
- How has the market performed over the last five years?
- What are the main segments that make up China's biotechnology market?
Key Highlights
The biotechnology market consists of the development, manufacturing, and marketing of products based on advanced biotechnology research.
The Chinese biotechnology market is expected to generate total revenues of $18.5bn in 2016, representing a compound annual growth rate (CAGR) of 8.4% between 2012 and 2016.
The Medical/Healthcare segment is expected to be the market's most lucrative in 2016, with total revenues of $18.1bn, equivalent to 97.8% of the market's overall value.
The Chinese government is seeking to help the domestic biotechnology industry through the creation of biotech zones and preferential regulations to locally produced drugs. It is hoped this will move Chinese companies away from cheap, generic drugs.
'
Executive Summary
Market value
Market value forecast
Category segmentation
Geography segmentation
Market rivalry
Market Overview
Market definition
Market analysis
Market Data
Market value
Market Segmentation
Category segmentation
Geography segmentation
Market Outlook
Market value forecast
Five Forces Analysis
Summary
Buyer power
Supplier power
New entrants
Threat of substitutes
Degree of rivalry
Leading Companies
Novo Nordisk A/S
Shanghai Kehua Bio-engineering Co., Ltd
Sinovac Biotech Ltd.
Macroeconomic Indicators
Country data
Methodology
Industry associations
Related MarketLine research
Appendix
About MarketLine
Table 1: China biotechnology industry value: $ million, 2012-16(e)
Table 2: China biotechnology industry category segmentation: $ million, 2016(e)
Table 3: China biotechnology industry geography segmentation: $ billion, 2016(e)
Table 4: China biotechnology industry value forecast: $ million, 2016-21
Table 5: Novo Nordisk A/S: key facts
Table 6: Novo Nordisk A/S: key financials ($)
Table 7: Novo Nordisk A/S: key financials (DKK)
Table 8: Novo Nordisk A/S: key financial ratios
Table 9: Shanghai Kehua Bio-engineering Co., Ltd: key facts
Table 10: Shanghai Kehua Bio-engineering Co., Ltd: key financials ($)
Table 11: Shanghai Kehua Bio-engineering Co., Ltd: key financials (CNY)
Table 12: Shanghai Kehua Bio-engineering Co., Ltd: key financial ratios
Table 13: Sinovac Biotech Ltd.: key facts
Table 14: Sinovac Biotech Ltd.: key financials ($)
Table 15: Sinovac Biotech Ltd.: key financial ratios
Table 16: China size of population (million), 2012-16
Table 17: China gdp (constant 2005 prices, $ billion), 2012-16
Table 18: China gdp (current prices, $ billion), 2012-16
Table 19: China inflation, 2012-16
Table 20: China consumer price index (absolute), 2012-16
Table 21: China exchange rate, 2012-16
Novo Nordisk A/S
Shanghai Kehua Bio-engineering Co., Ltd
Sinovac Biotech Ltd.
